NSC95397 is a Novel HIV-1 Latency Reversing Agent

Randilea Nichols Doyle(University of California, Los Angeles), Oliver I. Fregoso(University of California, Los Angeles)

bioRxiv (Cold Spring Harbor Laboratory)

May 25, 2023

10.1101/2023.05.24.542213

Cited by 2

Related Papers

NSC95397 Is a Novel HIV-1 Latency-Reversing Agent

|Viruses|2024|2